COVID-19: Consequences for Children With Cancer in Turkey and Globally
Turk Arch Pediatr
.
2021 Jul 1;56(4):295-299.
doi: 10.5152/TurkArchPediatr.2021.21134.
eCollection 2021 Jul.
Authors
Rejin Kebudi
1
,
Guillermo Chantada
2
3
4
,
Nilgün Kurucu
5
,
Deniz Tuğcu
6
,
Sheena Mukkada
7
,
Daniel C Moreira
7
Affiliations
1
Department of Pediatric Hematology-Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey.
2
Hemato-oncology Service, Hospital Pereira Rossell, Montevideo, Uruguay.
3
Hemato-oncology Service, Hospital Universitario Austral, Buenos Aires, Argentina.
4
Hospital Sant Joan de Deu, Hemato-oncology Service, Barcelona, Spain.
5
Department of Pediatric Oncology, Institute of Cancer, Hacettepe University School of Medicine, Ankara, Turkey.
6
Department of Pediatric Hematology-Oncology, Istanbul University School of Medicine,Istanbul,Turkey.
7
Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
PMID:
35005722
PMCID:
PMC8655955
DOI:
10.5152/TurkArchPediatr.2021.21134
No abstract available
Publication types
Review
Grants and funding
The authors declared that this study has received no financial support.